Description
APOXAR HCG GENERAL DESCRIPTION
Apoxar Human chorion gonadotrophic hormone (HCG for short) is a non-steroid protein hormone. The substance is produced by a pregnant woman’s placenta. The protein hormone is produced in the first 6-8 weeks of pregnancy and subsequently allows for the secretion of estrogen and progestogen in the corpus luteum. As a result, the production of these substances starts in the placenta itself. Chorion gonadotrophic hormone follows the bloodstream to the kidneys, after which it is excreted from the body through urine. Then it is purified in a laboratory environment and gets sold in the form of an injectable drug.
Chorion gonadotrophic hormone simplifies the process of ovulation in women – after the maturation of ovum, the hormone stimulates its release. HCG is no less in demand in sports as well. Chorion gonadotrophic hormone is used in bodybuilding to enhance the production of sex hormones and stimulate the functioning of the testicles, which improves the quality of spermatogenesis. Athletes use gonadotropin injections during anabolic steroid cycles to eliminate testicular atrophy.
APOXAR HCG BENEFITS
Human chorion gonadotrophic hormone has gained great popularity in sports. The protein hormone is characterized by its properties similar to the luteinizing hormone produced in the pituitary gland. In men, the luteinizing hormone stimulates the function of germ cells in the testes and activates the production of androgen hormones, which include testosterone.
Chorion gonadotrophic hormone injections are used in sports to speed up testosterone production. Following decreased dosages of steroid drugs or a complete cessation of their use, athletes experience setbacks and a decrease in strength performance. This is largely triggered by a decrease in the concentration of the primary male sex hormone.
As early as at the beginning of the anabolic-androgenic drug cycle, the functioning of the hypothalamic–pituitary–gonadal axis is observed to be impacted. Steroid substances increase the concentration of testosterone in the blood and sends the hypothalamus a specific signal, which then signals the pituitary gland to decrease or completely stop the production of follicle-stimulating hormones. As a result, luteinizing hormones do not begin to exert much effect on germ cells, where testosterone is produced. The additional use of human chorion gonadotrophic hormone allows for correcting the situation and activating the production of the natural male sex hormone.
The main positive effects of Apoxar HCG’s usage are as follows:
- stimulated production of sex hormones in the testicles – for this reason, the properties of chorion gonadotrophic hormone are similar to testosterone;
- stimulation of spermatogenesis in the male body;
- increased development of the genitals and the formation of secondary male sexual characteristics.
After ingestion, chorion gonadotrophic hormone starts its action almost immediately. Apoxar HCG provides a two-phase effect on the body: the first peak concentration of plasma testosterone in the blood occurs 2 hours after administration, the second peak occurs after 48-96 hours; at the same time, the average concentration of plasma testosterone increases, as the heights of the peak concentrations are directly proportional to the dosage.
APOXAR HCG POSSIBLE SIDE EFFECTS
During the use of chorion gonadotrophic hormone, side reactions similar to those of testosterone may occur. The cycle may manifest a high sex drive. Also at high dosages, the following undesirable symptoms may be observed acne, gynecomastia – swelling in the nipples, manifestation of lumps, itching, enlarged prostate, excessive hair growth throughout the body and baldness, masculinization symptoms (in women), fluid accumulation in muscle tissue, which adds swelling. Young athletes may experience premature completion of bone growth while using chorion gonadotrophic hormone. If the correct dosages are maintained, there are no adverse reactions.
APOXAR HCG ADMINISTRATION AND DOSAGE
Chorion gonadotrophic hormone is used during anabolic drug cycles, the duration of which exceeds 6 weeks, or in case several potent drugs are used in the same cycle. HCG use begins at week 2-4 of the cycle. Injections should be made twice a week at 250-500 IU. The use of gonadotropin does not end after the last steroid intake, but after the active agent of the steroid is excreted. This is followed by post-cycle therapy.
In some cases, dosages can be increased up to 2000 IU. Injections are administered every 2 days for 3 weeks. During longer steroid courses called “infinite” the protein hormone is administered continuously. However, every 4-5 weeks users need to take a break for 7-10 days. The use of gonadotropin to achieve an anabolic effect is impractical, since the result will not be as pronounced as when using steroids. Large dosages are required to achieve a noticeable result, about 4000 IU. Such doses can disrupt the endocrine profile and lead to lifelong infertility.
APOXAR HCG COMBINED CYCLES
Some athletes take HCG during post-cycle therapy after completing long steroid cycles. This is only possible if gonadotropin has not been used during the cycle itself.
The action of gonadotropin can block the restoration of natural hormones, but it is also necessary to trigger the recovery processes of the body after a steroid cycle. Injections should be made 3 weeks before the start of post-cycle therapy. When applied, the process looks like this: during a long steroid ester cycle users need to start HCG injections after the final intake of the anabolic drug; just by the time the medicine is administered, the steroid activity will end and PCT can begin. When using short esters or tableted steroids 3 weeks before the end of the cycle, users need to start using chorion gonadotrophic hormone.